Trehalose ameliorates the cryopreservation of cord blood in a preclinical system and increases the recovery of CFUs, long‐term culture‐initiating cells, and nonobese diabetic‐SCID repopulating cells

Abstract

Trehalose at 5 percent significantly ameliorates the cryopreservation of CB progenitor cells at a preclinical protocol. The increased recoveries of these cells might potentially improve the engraftment outcomes of CB transplants.